Performance
Trailing returns
| 1 day |
| -0.29% | |||
| 1 week | +1.63% |
| |||
| 4 week | +5.57% |
| |||
| 3 month | +9.04% |
| |||
| YTD | +17.71% |
| |||
| 1 year | +33.82% |
| |||
| 3 years* | +14.19% |
| |||
| 5 years* | +4.82% |
| |||
| *annualized | |||||
| Best 3 month return | +32.08% | |
| Worst 3 month return | -27.87% |
Morningstar statistics
Morningstar category: Large Value
| Return | Risk | Rating | |
| 3 years | Below Average | Above Average |
 
|
| 5 years | Average | Average |
|
| 10 years | Low | Average |
|
| Overall | Below Average | Average |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 4.89B | |
| Front load | 5.75% | |
| Deferred load | - | |
| Expense ratio | 1.10% | |
| Management fee | - | |
| Fund family | Putnam |
Asset allocation
| Cash | 0.79% | |
| Stocks | 98.42% | |
| Bonds | 0.00% | |
| Preferred | 0.28% | |
| Other | 0.51% |
Purchase information
| Initial | $0 |
17.63+0.20(1.15%)
May 17, 4:00PM EDT
Overall Morningstar RatingTM
Description
The investment seeks capital growth and current income. The fund invests mainly in common stocks of large U.S. companies, with a focus on value stocks that offer the potential for capital growth, current income, or both. Value stocks are issued by companies that the advisor believes are currently undervalued by the market. The adviser may consider, among other factors, a company's valuation, financial strength, growth potential, competitive position in its industry, projected future earnings, cash flows and dividends when deciding whether to buy or sell investments.
Fund filings (PDF) »
Fund filings (PDF) »
Asset manager:
Robert Ewing (Started: Nov 26, 2008)
Robert Ewing (Started: Nov 26, 2008)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 0.81 | -3.34 | -0.78 | -1.95 | |
| Beta* | 1.16 | 1.16 | 1.09 | 1.09 | |
| Mean annual return | 1.63 | 1.00 | 0.56 | 0.61 | |
| R-squared* | 90.66 | 97.30 | 97.44 | 96.00 | |
| Standard deviation | 12.44 | 17.72 | 20.84 | 16.24 | |
| Sharpe ratio | 1.56 | 0.67 | 0.31 | 0.35 | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| JPMorgan Chase & Co (JPM) | 3.49% | |
| Citigroup Inc (C) | 2.49% | |
| Pfizer Inc (PFE) | 2.45% | |
| Johnson & Johnson (JNJ) | 2.27% | |
| Wells Fargo & Co (WFC) | 2.04% | |
| Chevron Corp (CVX) | 1.83% | |
| Merck & Co Inc (MRK) | 1.81% | |
| Bank of America Corporation (BAC) | 1.75% | |
| Honeywell International, Inc. (HON) | 1.51% | |
| General Electric Co (GE) | 1.40% |